- BSRC Fleming
- Sep 22
- 1 min read
Updated: Oct 14
INOLYSIS Engages with Biotech Leaders at Bio3 Startup Pitching
We are excited to share that INOLYSIS participated in Session 21a – Startup Pitching at Bio3: BioInnovation Greece, held at Innovathens on September 9th. This session brought together pioneering startups, biotech leaders, and healthtech innovators from Greece and abroad to present their cutting-edge solutions.
Our Chief Medicinal Chemist, Alexios Matralis, represented INOLYSIS, showcasing our commitment to advancing therapeutic innovation and translating groundbreaking research into tangible healthcare solutions.
Bio3 provides a unique platform for startups like INOLYSIS
to engage with experts, investors, and fellow innovators, fostering collaboration, mentorship, and knowledge exchange. Participating in this session allowed us to highlight our work, gain valuable insights, and strengthen connections within the biotech ecosystem.
We are proud to be part of this dynamic community and look forward to continuing our journey of innovation, impact, and growth in the field of therapeutics.
